Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000444011 | SCV000516663 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001086804 | SCV000559811 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313042 | SCV000847357 | benign | Inborn genetic diseases | 2016-07-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000456510 | SCV001143804 | benign | not provided | 2018-09-25 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000444011 | SCV002069403 | benign | not specified | 2019-06-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000456510 | SCV003917347 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV000456510 | SCV005294119 | benign | not provided | criteria provided, single submitter | not provided |